“We come to work and do things nobody has done before”
QB3 Alumni, Loren Perelman, PhD
Director of Quality and Analytics @BoltThreads
A Conversation with John Milligan, CEO of Gilead Sciences
Gilead is known worldwide for its antiviral therapies. May 11, Threshold Pharmaceuticals CEO Barry Selick, a former UCSF postdoc, will engage Gilead's CEO John Milligan—another former UCSF postdoc—in a public Q&A about his career and leadership.
Get Inspired in Medtech
Register for the Rosenman Symposium, our annual medtech conference, scheduled for June 21, 2017.
Incubators at QB3
Find lab space at one of our five incubators close to UC faculty and resources.
Your career in the life sciences starts here. Check current job listings at startups in the Bay Area.
Impact in Numbers
Partner with us to gain access to the most innovative life science startups, and make your next big strategic investment.